Biologics are medications made from organic materials that can be used to treat a wide range of illnesses, and they are frequently used to treat immune-related illnesses such Crohn's disease, psoriasis, ankylosing spondylitis, and rheumatoid arthritis. The interesting aspect is that biologics are separated from various natural sources, whether they be carbohydrates, proteins, nucleic acids, or a complex mixture of these materials. The main types of biologics are monoclonal antibodies (MAbs), therapeutic proteins, and vaccines. Monoclonal antibodies, or mAbs, are created in a laboratory to combat a specific infection. The various route of administration includes oral, parenteral, and others that are distributed by hospital pharmacies, retail pharmacies/ drug stores, and others. The biologics market research report is one of a series of new reports from The Business Research Company that provides biologics market statistics, including biologics industry global market size, regional shares, competitors with a biologics market share, detailed biologics market segments, market trends, and opportunities, and any further data you may need to thrive in the biologics industry. This biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global biologics market is expected to grow from $382.04 billion in 2022 to $416.65 billion in 2023 at a compound annual growth rate (CAGR) of 9.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, and affecting many markets across the globe. The biologics market is expected to reach $599.62 billion in 2027 at a CAGR of 9.5%. Technology is expected to be a continued driver of market growth during this period. An area of particular development is likely to be physiology simulation modeling. Markets such as this one will benefit from the greater efficiencies offered by developments in this area. For example, Eli Lilly and Pfizer have adopted Amazon’s Elastic Compute Cloud (EC2) platform to conduct simulation models in early drug discovery that have been operational within hours, whereas traditional models would have taken weeks to conduct simulations. The Open Innovation Drug Discovery program is another initiative by Lilly to enhance the research and development of biologics. Such technological advances are likely to reduce costs and expedite the development phase of biologics, allowing companies to launch their products early. The early generation of biologics is losing its patent protection and is expected to face greater competition going forward from the entry of biosimilars into the market. Biosimilars are pharmaceuticals that are developed to have similar properties to a biological drug that has already been approved. Demand for biosimilars is being fueled by governments around the world trying to reduce healthcare costs. In India, a new biosimilar policy called the ‘Guidelines on Similar Biologics’ prepared by the Central Drugs Standard Control Organization (CSDCO) is expected to give a major boost to the Indian biosimilars industry. In the EU, a pathway for approving biosimilar medicines has existed since 2003. These less expensive alternatives increase the competitiveness of the biologics market putting downward pressure on pricing and market value growth. The US Food and Drug Administration (FDA) has revised its regulations to eliminate outdated biologics requirements, thus allowing drug manufacturers to employ new manufacturing technologies and testing capabilities. Standard preparations (standard solutions containing a precisely known concentration of an element), which help to ensure the safety, purity, and potency of biologics can now be obtained from sources other than FDA’s Center for Biologics Evaluation and Research (CBER) or can be developed internally by the biologics license applicant. The FDA has also removed a rule (Section 610.21 of FDA code) that specifies minimal potency limits to be met for certain antibodies and antigens. In addition, FDA is also updating regulations (Section 610.53 of FDA code) regarding storage periods and storage conditions for biologics. These amendments in regulations are expected to increase regulatory flexibility by allowing the pharmaceutical industry and the FDA to incorporate current scientific technologies in the manufacture of licensed biological products. Major companies in the biologics market include AbbVie, Johnson & Johnson, Amgen, Sanofi S.A, F. Hoffmann-La Roche Ltd., GlaxosmithKline, Novartis AG, Pfizer Inc., Teva Pharmaceuticals and CSL. North America was the largest region in the biologics market in 2022. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the biologics market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam. The biologics market consists of sales of Tumor necrosis factor inhibitors, Interleukin inhibitors, B-cells inhibitors, and T-cells inhibitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global biologics market is segmented - 1) By Type: Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribtuion Channels 3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration 4) By Drug Classification: Branded Drugs, Generic Drugs 5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs Subsegments Covered: Anti-Cancer MAbS, Immunological MAbS, Anti-Infective Monoclonal Antibodies (MAbs), Neuropharmacological MABS, Cardiovascular And Cerebrovascular MAbS, Other Monoclonal Antibodies (MAbs), Metabolic Disorders Therapeutic Proteins, Cancer Therapeutic Proteins, Cardiovascular Therapeutic Proteins, Immunological Therapeutic Proteins, Other Therapeutic Proteins, Anti-Infective Vaccines, Autoimmunity Vaccines, Other Vaccines

Medical equipment are devices that can be instrument, apparatus or machine that can be used in the prevention, diagnosis or treatment of illness or disease, or for detecting, measuring, restoring, correcting or modifying the structure or function of the body for health purpose. The main types of medical equipment are in-vitro diagnostics, dental equipment and supplies, ophthalmic devices, diagnostic imaging equipment, cardiovascular devices, hospital supplies, surgical equipment, orthopedic devices, patient monitoring devices, diabetes care devices, nephrology and urology devices, ENT devices, anesthesia and respiratory devices, neurology devices, and wound care devices. In-vitro diagnostics are tests done on samples like blood or tissue that is taken from the human body. In-vitro diagnostics will detect diseases or other conditions and are used to monitor a person’s overall health to cure, treat, or prevent diseases. The type of expenditure involved is public and private. The various product are instruments/equipment and disposables. The various end users involved are hospitals and clinics, homecare, diagnostics centres, and others. The medical equipment market research report is one of a series of new reports from The Business Research Company that provides medical equipment market statistics, including medical equipment industry global market size, regional shares, competitors with a medical equipment market share, detailed medical equipment market segments, market trends and opportunities, and any further data you may need to thrive in the medical equipment industry. This medical equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global medical equipment market grew from $639.75 billion in 2022 to $695.05 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The medical equipment market is expected to grow to $922.39 billion in 2027 at a CAGR of 7.3%. The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence is expected to rise by 57% globally, by the year 2020. This is increasing the demand for medical devices used in the diagnosis, prognosis, and treatment of several diseases, thereby driving the demand for medical equipment. These factors are expected to increase the patient pool globally, thereby driving the market during the forecast period. Regulatory changes are likely to lead to increased costs relating to new product development and service offerings to clients. These changes are related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes. For instance, according to cookieyed data 2021, in the US, PwC reported that 68% of 200 businesses surveyed intended to spend between $1 million and $10 million to comply with GDPR regulations. The GDPR regulation is an EU law on data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. Additionally, the FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. The potential loss of revenue due to delays in product release and additional costs incurred due to stringent approval processes puts a strain on investments relating to new product development, thereby affecting the growth of the medical equipment market. Device performance and patient data are available to healthcare service providers and are helping them to improve patient monitoring and overall care quality. Some companies are integrating medical device data with EMR (Electronic Medical Records) to improve transparency and collaboration. As consumer wearables are becoming more common, patient data volumes are increasing and companies are investing in deploying data management, warehousing, and security technologies. For example, Medtronic launched a tool to augment their cardiac devices to securely transfer device data to doctors and allow them to monitor the critical health indicators of their patients. Major companies in the medical equipment market include Medtronic Inc., Abbott Laboratories, Johnson & Johnson, Cardinal Health, Inc., Becton Dickinson, Siemens AG, STRYKER CORPORATION, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., and Boston Scientific Corporation. North America was the largest region in the global medical equipment market in 2022. Asia-Pacific was the second largest region in the global medical equipment market. The regions covered in the medical equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the medical equipment market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The medical equipment market consists of sales of devices used in the diagnosis, treatment and monitoring of medical conditions. The market includes diagnostic devices, imaging devices, surgical devices and patient monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global medical equipment market is segmented - 1) By Type: In-Vitro Diagnostics, Dental Equipment And Supplies, Ophthalmic Devices, Diagnostic Imaging Equipment, Cardiovascular Devices, Hospital Supplies, Surgical Equipment, Orthopedic Devices, Patient Monitoring Devices, Diabetes Care Devices, Nephrology And Urology Devices, ENT Devices, Anesthesia And Respiratory Devices, Neurology Devices, Wound Care Devices 2) By Type of Expenditure: Public, Private 3) By Product: Instruments/Equipment, Disposables 4) By End User: Hospitals And Clinics, Homecare, Diagnostics Centers, Other End Users Subsegments Covered: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment, Therapeutic Dental Equipment, General Dental Devices And Equipment, Dental Diagnostic Imaging Devices And Equipment, Dental Surgical Devices And Equipment, Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmic Devices And Equipment, X-Ray Systems Devices And Equipment, Ultrasound Systems Devices And Equipment, Computed Tomography (CT) Scanners Devices And Equipment, Magnetic Resonance Imaging Systems Devices And Equipment, Cardiovascular Monitoring And Diagnostic Devices And Equipment, Nuclear Imaging Devices And Equipment, Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment, Disposable Hospital Supplies, Sterilization Equipment And Disinfectants, Mobility Aids And Transportation Equipment, Operating Room Equipment, Surgical Sutures And Staples, Handheld Surgical Devices And Equipment, Electrosurgical Devices And Equipment, Joint Reconstruction Devices And Equipment, Spinal Surgery Devices And Equipment, Trauma Fixation Devices And Equipment, Orthobiologics Devices And Equipment, Arthroscopy Devices And Equipment, Orthopedic Braces And Support Devices And Equipment, Craniomaxillofacial (CMF) Devices And Equipment, Orthopedic Prosthetics, Orthopedic Accessories,, Fetal And Neonatal Monitoring Devices, Weight Monitoring And Body Temperature Monitoring Devices And Equipment, Vital Parameter Monitoring Devices And Equipment, Remote Patient Monitoring Devices And Equipment, Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters, Dialysis Devices And Equipment, Urinary Stone Treatment Devices And Equipment, Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment, Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment, Endoscopy Devices And Equipment, Hearing Aid Devices And Equipment, Hearing Diagnostic Devices And Equipment, ENT Surgical Devices And Equipment, Hearing Implants, Voice Prosthesis Devices And Equipment, Nasal Splints, Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables, Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Devices, Traditional Adhesive Dressings, Negative-pressure Wound Therapy (NPWT), Traditional Gauze Dressings, Advanced Wound Care Devices

Orthopedic braces and support devices and equipment are primarily used in injury prevention, injury rehabilitation, post-operative care, and osteoarthritic care. The main types of orthopedic braces and support devices and equipment are lower extremity braces, upper extremity braces, back, and hip braces, and other braces. Lower extremity braces are the braces that are used to support the ankle, foot, knee, and hip and are used in various applications. The various products are soft and elastic braces and supports, hinged braces and supports, and hard and rigid braces and support that are used by hospitals, home healthcare, clinics, and other end-users. The orthopedic braces and support devices and equipment market research report is one of a series of new reports from The Business Research Company that provides orthopedic braces and support devices and equipment market statistics, including orthopedic braces and support devices and equipment industry global market size, regional shares, competitors with a orthopedic braces and support devices and equipment market share, detailed orthopedic braces and support devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic braces and support devices and equipment industry. This orthopedic braces and support devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global orthopedic braces and support devices and equipment market size will grow from $3.86 billion in 2022 to $4.08 billion in 2023 at a compound annual growth rate (CAGR) of 5.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The orthopedic braces and support devices and equipment market size is expected to grow to $4.98 billion in 2027 at a CAGR of 5.1%. The rise in the geriatric population is driving the orthopedic braces and support devices and equipment market. Elderly people are more prone to injuries as their bones and connective tissues weaken with age. For example, In the US 70% of the population aged between 50-70 years suffers from osteoarthritis and is likely to increase further in the forecast period. This is one of the major contributing factors to the growth of this market. High adoption of pain medications worldwide restraints the growth of the orthopedic braces and support devices market. As more amount of people relies on pain killers for pains related to orthopedic disorders instead of adopting the use of a proper support device/braces. For example, Americans consume 80% of the world's supply of painkillers including painkillers for orthopedic treatments, thereby, hindering the orthopedic braces and support devices and equipment market. Due to the increase in the demand for orthopedic braces and support devices and equipment, various companies are adapting themselves to use innovative technologies such as bionic energy savers to solve problems related to injuries in the knee, arms, or any other movable part of the body. For example, spring-loaded technology uses LevitationTM bionic knee brace that enhances mobility and provides strength to legs by storing energy when a person sits or rests. These technologies are providing a better quality of life to people and positively impact the growth of the market. 3M’s consumer health care division issued orders to recall ankle braces and supports as the product contained undeclared natural latex rubber which may lead to allergic reactions in a few users. FDA ranked the recall as Class 2, which are labeled as products causing a temporary health issue or pose a risk of minimal adversity. Thus, any product recall may hamper the market’s growth as it would create negative feedback regarding the product and people would hesitate to use the products. In April 2021, DJO, a global leader in braces and support devices acquired Medshape Inc. for an undisclosed amount. This acquisition, the portfolio includes innovative devices for, joint fusion, fracture fixation, and soft tissue injury repair that utilize biomaterial technologies designed to improve patient outcomes. Medshape Inc., a company operating in orthopedic braces and support devices market-based in Georgia. [xii] Major players in the orthopedic devices and equipment market are DJO Global, Bauerfeind AG, Otto Bock Healthcare GmbH, Breg, Inc., Ossur Hf, DeRoyal Industries, Inc., BSN Medical, Medi GmbH & Co. KG, THUASNE Group, 3M Company, and Lohmann & Rauscher. North America was the largest region in global orthopedic devices and equipment market in 2022. Western Europe was the second-largest region in global orthopedic devices and equipment market. The regions covered in the orthopedic braces and support devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the orthopedic devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, USA, and Australia. The orthopedic braces and support devices and equipment market consist of sales of soft & elastic braces and supports, hard braces and supports, and hinged braces and supports. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global orthopedic braces and support devices and equipment market is segmented - 1) By Type: Lower extremity braces, Upper extremity braces, Back and hip braces, Other braces 2) By End User: Hospitals, Home Healthcare, Clinics, Other End-Users 3) By Product: Soft & Elastic Braces and Supports, Hinged Braces and Supports, Hard & Rigid Braces and Supports

Orthopedic accessories refer to the products that are used to fix or remove implants from the body. The main types of orthopedic accessories devices (or) equipment are bone cement, casting system, and removal system. Bone cement is the biomaterial obtained by mixing a powder phase and a liquid phase, which is molded and implanted as a paste and can be set once implanted in the body. The various application is hip, knee, and spine. The various end-users include hospitals, orthopedic clinics, and trauma fixation centres. The orthopedic accessories devices (or) equipment market research report is one of a series of new reports from The Business Research Company that provides orthopedic accessories devices (or) equipment market statistics, including orthopedic accessories devices (or) equipment industry global market size, regional shares, competitors with a orthopedic accessories devices (or) equipment market share, detailed orthopedic accessories devices (or) equipment market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic accessories devices (or) equipment industry. This orthopedic accessories devices (or) equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global orthopedic accessories market size will grow from $3.25 billion in 2022 to $3.36 billion in 2023 at a compound annual growth rate (CAGR) of 3.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The orthopedic accessories market size is expected to grow to $3.82 billion in 2027 at a CAGR of 3.2%. The increase in the number of medical cases due to road and sports accidents is driving the Orthopaedic Accessories market. The probability of bones and other muscle tissues getting ruptured is high in the road and sports accidents, thus requiring orthopedic accessories like arm support, knee braces, and hip support for providing rigid support to the ruptured tissue and broken joint/bones during the treatment. Orthopaedic accessories immobilize the bones and give them time to heal. Also, orthopaedic accessories like bone cement and casting help in joining broken bones and filling in the void present in or between the bones. According to a report published by WHO, around 20-50 million people globally receive non-fatal injuries every year due to road accidents. Similarly, according to a survey by Stanford Children's Health, more than 3.5 million children aged 14 or younger get hurt every year by playing sports or by participating in some recreational activity. As the number of road and sports accidents increases, the number of medical cases requiring orthopaedic accessories to get proper treatment will increase, thus driving the orthopaedic accessories market. The high rate of product recalls is restraining the Orthopedic Accessories market. Product Recall is a process of retrieving all defective products that have been sold or are available in the market. If an orthopedic Accessories company recalls a product from the market, the company takes up all the cost of fixing the defective product and the cost of replacement. This cost of replacement for large companies can go up to multi-billion dollars, hence restraining the growth of the company and for the whole market as well. For example, in the year 2022, DePuy Orthopedics recalled its Modular Cathcart Fracture Head Hip Ball due to issues in its how to use guide. According to a study by researchers of the University of Texas Medical and Naval Medical Center, Orthopedic devices represented 12% of all medical device recalls. This high recall rate is affecting the sales of orthopedic accessories and resulting in additional costs for manufacturing companies, in terms of repair and replacement of those devices, thus hampering the growth of the market. Companies in the orthopedic accessories market are increasingly using 3D printing technology to improve production efficiency and for making customized accessories as per the patient's requirements. 3D Printing technology is a process of making complex structures that are built by stacking up thin layers of a material and cutting out unwanted parts. In the case of orthopedic treatment, many people have different body shapes and sizes. 3D Printing allows companies to manufacture accessories as per the requirement of the patient. For example, the ZSFab company used 3D Printing technology to manufacture orthopedic accessories like neck braces and wrist casts. Also, companies like Stryker, Medtronic, and Smith & Nephew are working on 3D printing to improve manufacturing efficiencies and product quality. The orthopedic accessories market is regulated by authorities such as the US FDA and the Europen Council. For instance, EU Medical Devices Regulation (MDR 2017/745) is set to replace 2 existing directives, and this new regulation will come into effect by 2020. As per this, orthopedic accessories manufacturers need to maintain a unique device identity to improve device traceability, including aesthetic devices that have the same characteristics and risks profile as that of analogous medical devices. The regulation mandates the manufacturers to introduce an Implant card, which would contain information about the implanted medical device for a patient. MDR 2017/745 also aims at strengthening post-market surveillance requirements for manufacturers and setting high standards of quality and safety for medical devices for the health and safety of patients and users. Similarly, the management system standard for medical devices - ISO 13485 has been updated. In Conventus Orthopedics, a US-based commercial stage orthopedics company acquired Flower Orthopedics for an undisclosed amount. The acquisition would be an opportunity for Conventus to tackle ongoing concerns regarding viral and infection risks with heavy reusable orthopaedic implant trays. Flower Orthopedics is a US-based manufacturer of single use implant and instrument kits. Major players in the orthopedic accessories devices (or) equipment market are Stryker Corporation, Zimmer-Biomet Holding, DePuy Synthes, Smith and Nephew PLC., McDavid, Aesculap Implant System, Conmed Corporation, Donjoy, NuVasive, and Medtronic PLC. North America was the largest region in the global orthopedic accessories devices (or) equipment market in 2022. Western Europe was the second-largest region in the orthopedic accessories devices (or) equipment market. The regions covered in the global orthopedic accessories devices (or) equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the orthopedic accessories devices (or) equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The orthopedic accessories market consists of sales of products such as bone cement, casting system, and removal system. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global orthopedic accessories market is segmented - 1) By Type: Bone Cement, Casting System, Removal System 2) By Application: Hip, Knee, Spine 3) By End User: Hospital, Orthopedic Clinic, Trauma Fixation Center

Orthopedic biomaterials are materials intended to be inserted into the human body as constituents of devices designed to perform certain biological functions by either substituting or repairing various tissues, such as bones, cartilage, ligaments, tendons, and others. The orthopedic biomaterials market covered in this report is segmented by material type into ceramics and bioactive glasses, calcium phosphate cement, polymers, metal, and composites. Polymers are used as orthopedic biomaterials intended to be inserted into the human body as constituents. The various applications are orthopedic implants, joint replacement/reconstruction, bio-resorbable tissue fixation, orthobiologics, and viscosupplementation. These are used by various end-users such as hospitals, clinics, and others. The orthopedic biomaterials market research report is one of a series of new reports from The Business Research Company that provides orthopedic biomaterials market statistics, including orthopedic biomaterials industry global market size, regional shares, competitors with a orthopedic biomaterials market share, detailed orthopedic biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic biomaterials industry. This orthopedic biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global orthopedic biomaterials market grew from $16.9 billion in 2022 to $18.62 billion in 2023 at a compound annual growth rate (CAGR) of 10.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The orthopedic biomaterials market is expected to grow from $29.69 billion in 2027 at a CAGR of 12.4%. The rise in the incidence of musculoskeletal disorders is expected to drive the orthopedic biomaterials market. According to the World Health Organization (WHO) report, musculoskeletal conditions are the leading contributor to disability worldwide. About 20-33% of the population suffer from a musculoskeletal disability. Musculoskeletal disorders induce fractures, swelling, and discomfort in the joints, ligaments, and tendons that cause movement disabilities. The burden of musculoskeletal conditions is known to increase with age. The sustainable development goals (SDGs) and the Decade of Healthy Ageing 2020–2030 have called for increased global attention and action on musculoskeletal health. Biomaterials are used to treat these disorders. Hence, the incidence of musculoskeletal disorders is projected to drive the orthopedic biomaterials market. The high cost of conducting clinical trials is expected to hinder the biomaterials market growth. The orthopedic biomaterials are directly implanted in the body. Therefore, it is important to prove the safety and biocompatibility of these materials. However, the high cost of conducting clinical trials is acting as a major roadblock. The clinical studies are expensive and time-consuming due to the number of tests required, and the length of each test. The investment of resources, time, and funding grows with successive stages. Additional costs are associated with the result of the trials at different phases. For instance, the cost of a failed phase 3 trial is not just the cost associated with the trial itself but the cost of all prior trials as well as the cost of lost time pursuing a potentially viable alternative or repeating the steps. Therefore, the high cost of conducting clinical trials is expected to impact the orthopedic biomaterials market. 3D printing of orthopedic implants is one of the recent developments in the orthopedic biomaterials market. 3D printing technology is used to produce a large range of medical equipment, such as those with complicated structures or characteristics to suit a patient’s particular anatomy. 3D printing of orthopedic implants enables the design of more natural anatomical shapes, as well as the design of porous bone replacement scaffolds that can be easily integrated into the design of the implant. This allows natural bone regeneration to generate higher reliability of the implant. 3D printing of orthopedic implants is a trend in the orthopedic biomaterial market that is attracting many players. For instance, Evonik, a Germany-based chemical company has invested in Meditool, a Chinese-based 3d printed implant start-up that produces models and implants by using polyether ketone (PEEK) polymer supplied by Evonik. In November 2020, Olympus, a Japanese medical technology company, acquired FH Ortho for an undisclosed amount. The acquisition would help Olympus to grow in the field of orthopaedic minimally invasive surgery. FH Ortho is a France based orthopaedics company. Major players in the orthopedic biomaterials market are Zimmer Biomet Holdings Inc., Stryker Corporation, Victrex PLC (Invibio Ltd.), Globus Medical Inc., CAM Bioceramics B.V., Heraeus Holding GmbH, Exactech Inc., Collagen Matrix Inc., Evonik Industries AG, and Koninklijke DSM N.V. (DSM Biomedical B.V.). North America was the largest region in the orthopedic biomaterials market in 2022. Western Europe was the second largest region in the global orthopedic biomaterials market report. The regions covered in the global orthopedic biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the orthopedic biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The orthopedic biomaterials market consists of sales of glass-ceramic and bioactive glasses and calcium phosphate cements. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global orthopedic biomaterials market is segmented - 1) By Material Type: Ceramics & Bioactive Glasses, Calcium Phosphate Cements, Polymers, Metal, Composites 2) By Application: Orthopedic Implants, Joint Replacement/Reconstruction, Bio-Resorbable Tissue Fixation, Orthobiologics, Viscosupplementation 3) By End-User: Hospitals, Clinics, Other End-Users

Orthopedic power tools refer to tools used to perform surgery on bone or bone fragments. These tools perform functions like drilling, sawing, reaming, screwing, and others. Orthopedic power tools are employed in every area of orthopedic surgery, from wound treatment by pulse lavage to drilling and reaming in long bone fractures with screws and intramedullary nails. The main products of orthopedic power tools are large bone orthopedic power tools, small bone orthopedic power tools, high speed bone orthopedic power tools, and orthopedic reamers. Large bone orthopedic power tools are developed for treatments like hip and complete knee replacements, reaming, intramedullary nailing, drilling, and driving screws in large bones. These tools allow orthopedician to conveniently handle complex surgeries. These tools are used on various power sources which include pneumatic powered, battery operated, and electric powered. The orthopetic power tools are mostly used by orthopedic hospitals, orthopedic clinics and ambulatory surgical centers for treating various orthopedic related ailments. The orthopedic power tools market research report is one of a series of new reports from The Business Research Company that provides orthopedic power tools market statistics, including orthopedic power tools industry global market size, regional shares, competitors with an orthopedic power tools market share, detailed orthopedic power tools market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic power tools industry. This orthopedic power tools market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global orthopedic power tools market size grew from $1.07 billion in 2022 to $1.13 billion in 2023 at a compound annual growth rate (CAGR) of 5.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The orthopedic power tools market size is expected to grow to $1.38 billion in 2027 at a CAGR of 5.2%. The increasing prevalence of orthopedic disorders among the global population is expected to boost the orthopedic power tools market. The focus of orthopedics is the treatment of abnormalities or functional limitations of the skeletal system, notably the spine and its accompanying structure, ligaments, and muscles. The orthopedic power tools are used for treating these orthopedic ailments. For example, according to the WHO, approximately 1.71 billion people had musculoskeletal conditions worldwide in 2021. Hence the demand for orthopedic power tools is expected to increase in the forecast period as there is an increase in orthopedic disorders. Adoption of advanced and innovative technology is a key trend in the orthopedic power tools market. Innovation for sterilizing the orthopedic power tools is taking place to improve the efficiency of the treatment procedure. For Instance, in May 2021, Arbutus Medical launched SteriTrak, a new kit to help trauma centers execute bone traction more efficiently and quickly while ensuring cleanliness. The kit allows the emergency departments to quickly acquire sterile bone traction equipment when time is limited. SteriTrak helps apply temporary traction under a minute in case of terrible bone fractures. In December 2020, Zimmer Biomet, a US-based medical device company, acquired A&E Medical Corp in an all cash deal valued to be about $250 million. As a part of the acquisition, Zimmer Biomet will have access to the complete portfolio of A&E Medical which includes sternal closure devices—including sternal sutures, cable systems, and rigid fixation—along with a range of single-use complementary temporary pacing wire and surgical punch products. With the addition of this protfolio, Zimmer Biomet will attain the capabilities to offer a comprehensive suite of sternal closure products, including rigid fixation and address a variety of unmet patient and surgical needs. Major players in the orthopedic power tools market are De Soutter Medical, B Braun Melsungen AG, Aygun Surgical Instruments Co Inc., Medtronic plc, DePuy Synthes Companies, Zimmer Biomet, Stryker Corporation, Exactech Inc., Nouvag AG, Medical Bees GmbH, IMedicom Co Ltd., Adeor Medical AG, Shanghai Bojin Medical Instrument, Allotech Co Ltd., Adeor, ceterixorthopeddics, Orthopromed and MatOrtho. North America was the largest region in the orthopedic power tools market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in orthopedic power tools market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the orthopedic power tools market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The orthopedic power tools market consists of sales of battery, pneumatic, and electric. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global orthopedic power tools market is segmented - 1) By Product Type: Large Bone Orthopedic Power Tools, Small Bone Orthopedic Power Tools, High Speed Bone Orthopedic Power Tools, Orthopedic Reamers 2) By Technology: Pneumatic Powered, Battery Operated, Electric Powered 3) By End User: Orthopedic Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers

Orthopedic regenerative surgical products are used for the treatment of joint pains, gout, articular defects, fibromyalgia, and osteoarthritis, as well as trauma and joint replacement, joint problems, regenerative orthopedic medicine using platelet-rich plasma (PRP) which is frequently the nonsurgical treatment of choice to assist patients in healing and repairing many musculoskeletal (orthopedic) injuries such as joint, tendon, ligament, and muscular injuries. The orthopedic regenerative surgical products are curing many other musculoskeletal injuries. The main type of orthopedic regenerative surgical products is allograft, synthetic, cell-based, and viscosupplements. Allograft is a tissue transplant between genetically distinct individuals of the same species. An allograft is not the same as an autograft, which uses tissue from the same person's body and is thus genetically identical. Anterior tibialis tendon, frozen femoral head, freeze-dried bone chips, DBM putty, acellular dermis, and amniotic membrane are examples of human allografts. These are used by hospitals, ambulatory surgical centers, and others, in the treatment of orthopedic pain management, trauma repair, cartilage and tendon repair, and joint reconstruction. The orthopedic regenerative surgical products market research report is one of a series of new reports from The Business Research Company that provides orthopedic regenerative surgical products market statistics, including orthopedic regenerative surgical products industry global market size, regional shares, competitors with a orthopedic regenerative surgical products market share, detailed orthopedic regenerative surgical products market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic regenerative surgical products industry. This orthopedic regenerative surgical products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global orthopedic regenerative surgical products market size grew from $3.89 billion in 2022 to $4.2 billion in 2023 at a compound annual growth rate (CAGR) of 8.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The orthopedic regenerative surgical products market size is expected to grow to $5.38 billion in 2027 at a CAGR of 6.4%. The rising prevalence of orthopedic diseases across the globe is likely to contribute to the growth of the orthopedic regenerative surgical products market. The orthopedic regenerative surgical products contribute to the prevention of orthopedic problems such as fractures, sprains, and strains, as well as lifelong conditions associated with ongoing functional limitations and disability. Approximately 1.71 billion people have musculoskeletal conditions worldwide. The orthopedic disease musculoskeletal conditions are the leading contributor to disability worldwide, with low back pain being the single leading cause of disability in 160 countries. Hence, the rising prevalence of orthopedic diseases drives the market for orthopedic regenerative surgical products. Technological advancements are a key trend gaining popularity in the orthopedic regenerative surgical products market. For instance, in 2021, the USA-based Anika Therapeutics, Inc., a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology, announced the successful completion of the first human surgical procedure with its injectable HA-based bone repair therapy for the treatment of bone voids and other skeletal system bone defects caused by trauma or age-related degeneration. Around 900,000 people require treatment for bone voids and other bone defects of the knee, which cause pain and impaired function and may necessitate total joint replacement therapy. In 2021, Stryker, a US-based multinational medical technologies corporation, acquired OrthoSensor Inc for an undisclosed amount. This acquisition aimed to develop the medical & surgical, neurotechnology and spine that help improve patient and hospital outcomes. OrthoSensor Inc is a leader in the digital evolution of musculoskeletal care and sensor technology for total joint replacement. OrthoSensor's headquarters is in Dania Beach, USA. Major players in the orthopedic regenerative surgical products market are Baxter, Zimmer Biomet, Stryker, Smith&Nephew, Allosource, Amniox Medical Inc., Anika Therapeutics Inc., Vericel Corporation, Vsy Biotechnology GmbH, Aptissen S.A., Mimedx, and TissueTech Inc. North America was the largest region in the orthopedic regenerative surgical products market in 2022 and is also expected to be the fastest-growing region in the forecast period. The regions covered in orthopedic regenerative surgical products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the orthopedic regenerative surgical products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The orthopedic regenerative surgical products market consists of sales of allograft wedges, allowrap DS, BIO4, DBM, hydroset, imbibe, nerve repair, and prochondrix CR.Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global orthopedic regenerative surgical products market is segmented - 1) By Product: Allograft, Synthetic, Cell-based, Viscosupplements 2) By Application: Orthopedic Pain Management, Trauma Repair, Cartilage and Tendon Repair, Joint Reconstruction 3) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users

Orthopedic devices are used to stabilize the body posture by correcting deformities, restoring the function of the human skeletal system, articulations, and associated structures either by replacing or reinforcing the damaged part. The main types in the orthopedic devices market are joint reconstruction devices and equipment; spinal surgery devices and equipment, trauma fixation devices and equipment, orthobiologics devices and equipment, arthroscopy devices and equipment, orthopedic braces and support devices and equipment, and craniomaxillofacial (CMF) devices and equipment, orthopedic prosthetics. Spinal surgery devices are the devices used during spine surgery to stabilize the spine to prevent motion while fusion occurs between two or more vertebrae. The type of expenditure is public, private. The products used are instruments/equipment, disposables. The various end-users are hospitals and clinics, diagnostic laboratories, and others. The orthopedic devices market research report is one of a series of new reports from The Business Research Company that provides orthopedic devices market statistics, including orthopedic devices industry global market size, regional shares, competitors with a orthopedic devices market share, detailed orthopedic devices market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic devices industry. This orthopedic devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global orthopedic devices market grew from $43 billion in 2022 to $45.79 billion in 2023 at a compound annual growth rate (CAGR) of 6.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The orthopedic devices market is expected to grow to $55.75 billion in 2027 at a CAGR of 5.0%. The increase in the patient pool due to the rising geriatric population globally contributed significantly to the growth of the orthopedic devices market during the historic period. According to the World Health Organization, the number of people aged 60 years and above was 1 billion in 2020 and the number will rise to 1.4 billion by 2030 and it will reach 2.1 billion by 2050. This rise in the geriatric population increased the demand for medical care and drove the healthcare expenditure. These factors increased the demand for these products and drove the market during the historic period. The orthopedic devices market was limited by the development of new drugs and therapies which allow patients to avoid surgical procedures. With advances in tissue engineering, stem-cell therapy, and other treatment alternatives such as platelet-rich plasma (PRP) injections, patients can avoid surgical procedures for medical conditions such as arthritis, tendonitis, and others. This has negatively impacted the demand for orthopedic devices as an increasing number of people opted for these alternative treatment methods, to avoid risks and complications associated with orthopedic procedures. Biodegradable implants are increasingly being used in trauma orthopedic surgeries. Biodegradable implants are used to replace a missing biological structure, support a damaged biological structure, and enhance the existing bone structure. Biodegradable products such as reabosorbable polymers composed of polyglycolic acid and polylactic acid manufactured in the form of plates, screws, and pins are replacing traditional devices like plates and screws, which are more expensive. Surgeons are preferring biodegradable implants to replace conventional implants, as biodegradable implants can be engineered to provide temporary support for bone fractures; can degrade at a rate matching new tissue formation; can eliminate the need for the second surgery, and are highly useful in fracture fixation in children; and result in less implant-related infections. For instance, Stryker Corporation offers orthrobiologics such as bone repair biodegradable products that are used in bone regeneration and bone healing, soft tissue regeneration, and muscle connection to bone. Major companies in the orthopedic devices market include Johnson & Johnson, Zimmer Biomet Holdings, STRYKER CORPORATION, Medtronic Inc., Smith & Nephew plc, Colfax Corporation, NuVasive, Inc., Wright Medical Group, Inc., Globus Medical Inc., and B. Braun Group. North America was the largest region in the global orthopedic devices market in 2022. Western Europewas the second largest region in the global orthopedic devices market. The regions covered in the orthopedic devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the orthopedic devices market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The orthopedic devices market consists of sales of osteotomes, bone-cutting forceps, Gigli saws, and plate benders that are used for orthopedic surgeries and treatment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global orthopedic devices market is segmented - 1) By Type: Joint Reconstruction Devices And Equipment, Spinal Surgery Devices And Equipment, Trauma Fixation Devices And Equipment, Orthobiologics Devices And Equipment, Arthroscopy Devices And Equipment, Orthopedic Braces And Support Devices And Equipment, Craniomaxillofacial (CMF) Devices And Equipment, Orthopedic Prosthetics 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables